ImmunityBio

Public

San Diego, CaliforniaHealthcarehttps://www.immunitybio.com

Last Round

Post-IPO Financing

Mar 31, 2026

Total Funding Raised

$100M

Company Overview

ImmunityBio (NAS: IBRX) is a biotechnology company specializing in the discovery, development, and commercialization of advanced immuno- and cellular therapies that enhance the natural immune system to promote sustained immune responses.

Sector

Healthcare

AI Layer

Non-AI

Keywords

BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) treatmentinterleukin-15 (IL-15) receptor agonist immunotherapycancer immunotherapybladder-sparing cancer treatmenturology oncology therapeuticscell therapy for cancer and infectious diseaseantibody-cytokine fusion protein platformNK-92 cell-based therapyintravesical instillation therapyimmunotherapy for infectious diseaserecombinant protein vaccine platformDNA and RNA vaccine platform

ImmunityBio Comps

Public and private peers based on sector, stage, and business model.

ImmunityBio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ImmunityBio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Post-IPO Financing	Mar 31, 2026

View all Funding Rounds

ImmunityBio Investors

Notable investors and investment history

ImmunityBio investors
Investor	Rounds
Nant Capital, LLC	Post-IPO Financing
Oberland Capital Management	Post-IPO Financing

View all Investors

ImmunityBio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ImmunityBio Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSan Diego, California

Employee Range611

Year Founded2014

Last FundingMar 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.